Research Reports on investment opportunities丨Guosen: Maintains the "Outperform Market" rating for Medical, Target Price 34.15-39.84 yuan.

Gelonghui January 3 | Guosen's Research Reports indicate that Meihou Medical (301363.SZ) is a leading platform for medical instrument components, continuously extending its Business lines. The company has outstanding capabilities in Business expansion, having extended to other medical instruments products components and home and Consumer Electronics components. The impact of inventory reduction by home Ventilator customers has basically been eliminated, and Business growth on a month-on-month basis can be anticipated. Customer A is a leader in the global home Ventilator market, and the company has been a participant in the development of its core product components and a key supplier for mass production, maintaining a stable relationship for over ten years. In the short term, the company will face performance pressure starting in the second half of 2023 due to Customer A's inventory reduction, until Q2 2024.

Gelonghui FinanceJan 3 17:01 · Ratings

Meihao Medical (301363.SZ): has repurchased 0.48% of shares in total.

On January 3, Glonghui reported that Meihai Medical (301363.SZ) announced that as of December 31, 2024, the company has repurchased a total of 1,968,851 shares through its special securities repurchase account via centralized bidding trading, accounting for 0.4842% of the company's total share capital, with a highest Fill Price of 28.31 yuan/share, a lowest Fill Price of 22.80 yuan/share, and a total transaction amount of 50.0937 million yuan (excluding transaction fees).

Gelonghui FinanceJan 3 16:14

Meihao Medical (301363): Traditional Business Recovers Steady Growth, Promising Development Prospects for Emerging Business.

Meihao Medical is a leading platform for medical instrument components, continuously extending its Business lines. Established in 2010, after more than 10 years of focus, it has the capability to provide a full process service for the development of medical instrument components and products. Currently, its cornerstone Business is home-use respiratory equipment.

GuosenJan 3 10:37

Meihao Medical (301363): A leading manufacturer of Ventilator components, multi-faceted development adds new momentum.

Investment highlights: The company, as a leading provider of home Ventilators and artificial cochlear implants, has maintained stable long-term cooperation with major clients. Since 2024, with the alleviation of inventory reduction impacts from downstream major clients, the company’s revenue and profits have gradually improved.

ZheshangDec 18, 2024 00:00

Mei Hao Medical (301363.SZ): Malaysia's self-owned production base phases one and two have been put into production

Gelonghui, on November 27, reported that Meihao Medical (301363.SZ) stated on the investor interaction platform that the main foreign sales countries for the company are Singapore, Australia, and others. The company has its own production base in Malaysia, with the first and second phases already in operation and the third phase under construction, meeting the needs of different customers and various supply chain markets.

Gelonghui FinanceNov 27, 2024 15:26

Express News | The use of raised funds has changed, and Meihao Medical is intensifying its overseas layout.

BreakingsNov 22, 2024 02:48